FCM
SLAB icon

Fieldview Capital Management’s Silicon Laboratories SLAB Stock Holding History

Fieldview Capital Management’s Portfolio SLAB Stock Details SLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$704K Sell
3,219
-1,926
-37% -$417K 0.2% 154
2026
Q1 		$1.07M Buy
+5,145
New +$943K 0.31% 86
2025
Q3 		– Sell
-1,506
Closed -$222K – 522
2025
Q2 		$222K Buy
+1,506
New +$178K 0.03% 312

Other funds holding SLAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fieldview Capital Management's SLAB Position: Q2 2026 in Review

Fieldview Capital Management reduced its Silicon Laboratories (SLAB) stake by 37% in Q2 2026, selling an estimated $417K and leaving 3,219 shares worth $704K. The position accounts for 0.2% of the portfolio, ranked #154.

Fieldview Capital Management first reported a position in SLAB in Q2 2025 and has held it in 3 quarters since. The position peaked at $1.07M in Q1 2026. 352 funds tracked by Wall St. Rank hold SLAB as of Q2 2026.

  • Fieldview Capital Management held 3,219 shares of Silicon Laboratories worth $704K as of Q2 2026.
  • Fieldview Capital Management sold 1,926 Silicon Laboratories shares in Q2 2026, an estimated $417K.
  • Silicon Laboratories made up 0.2% of Fieldview Capital Management's portfolio in Q2 2026, its #154 holding.
  • Fieldview Capital Management first reported a position in Silicon Laboratories in Q2 2025 and has held it in 3 quarters since.
  • Fieldview Capital Management's Silicon Laboratories position peaked at $1.07M in Q1 2026.
  • 352 funds tracked by Wall St. Rank held Silicon Laboratories as of Q2 2026.

Based on Fieldview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.